Investigating the Influence of Patient Eligibility Characteristics on the Number of Deferrable Rheumatologist Visits: Planning for a Patient-Initiated Follow-Up Strategy
Authors' conclusion
However, the applicability of such models of care and the number of deferred visits is highly dependent on patient characteristics used to establish eligibility criteria for that model.
Study context
- Population
- Patients with rheumatoid arthritis (RA) seen in 7 rheumatologists' practices at 2 university-based clinics, March 1, 2021–February 28, 2022
- Participants
- 365 patients770 visits
- Exposure
- 4 eligibility criteria sets for patient-initiated follow-up
- Outcome
- Number (proportion) of potentially deferrable visits in patients with stable disease under different eligibility criteria sets
Methodological details2 university-based clinics, 7 rheumatologists' practices
- 2 university-based clinics
- 7 rheumatologists' practices
Main finding
As reported in the abstract
Proportion of deferrable visits across criteria sets
Proportion of visits that could be redirected, range among all criteria sets
2.5% and 20.9%
Highest proportion: eligibility of stable disease activity and csDMARD or no medications only
n = 161, 20.9%
Observational data: associations, not effects.
Original publication
Investigating the Influence of Patient Eligibility Characteristics on the Number of Deferrable Rheumatologist Visits: Planning for a Patient-Initiated Follow-Up Strategy. J Rheumatol. Published 1 February 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →